Evidence map›Paper›PMID 32975667›Full record

ArticleMedical oncology (Northwood, London, England)2020

Population mutation properties of tumor evolution.

LeeYoung Park

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

LeeYoung ParkNatural Science Research Institute, Yonsei University, Yonsei-ro 50, Seodaemun-Gu, Seoul, 03722, Korea. lypark@yonsei.ac.kr.ORCID http://orcid.org/0000-0003-3691-822X
Yonsei University · KR

Funding

Korea Institute of Science and Technology Information KSC-2017-C3-0052National Research Foundation of Korea 2015K1A3A1A14021223, 2018R1D1A1B07042910, and 2018K1A3A7A08089881
6 · The paper itself

Abstract

Tumor growth patterns differ depending on the individual tumor, leading to various patterns of genetic heterogeneity across tumors. Despite their importance, the population mutation properties of tumor evolution have not been well studied, especially in terms of overall genetic heterogeneity. The current study aims to examine factors in tumor evolution influencing overall genetic heterogeneity. Extensive simulations of the representative evolutionary patterns of various tumors were conducted in the current study to determine the overall genetic characteristics of tumor evolution. The variations in cell birth/death rates and angiogenesis duration were examined based on the simplest growth pattern of tumors with avascular growth, angiogenesis, and vascular growth. To examine the impact of evolutionary tree structure, three-step linear evolution and branching evolution were investigated based on various subpopulation initiation times. The population size during the initial growth phase and the duration of angiogenesis are important factors affecting overall genetic heterogeneity. Furthermore, the shape of the evolutionary tree is crucial for defining the genetic heterogeneity of the extant tumor cell population, indicating the importance of the initiation timing of subpopulations. Branching evolution results in slightly greater genetic heterogeneity in terms of allelic distribution than in terms of the number of variants. The results of the current study reveal that the pattern of tumor evolution is critical for defining tumor genetic heterogeneity. These population genetic approaches are important for understanding the properties of tumor cell populations.

Indexed as

Genetic HeterogeneityModels, TheoreticalMutationHumansNeoplasmsBranching growthGenetic heterogeneityLinear growthPopulation mutation parameterSimulationTumor evolution

Identifiers

PMID32975667
OpenAlexW3088837199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.